Meeting
2022 ASCO Genitourinary Cancers Symposium
Effect of PSMA-positive membranes secreted from prostate cancer cells on vascular endothelial cells.
Authors
Ryuta Watanabe
Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan
Ryuta Watanabe , Masashi Maekawa , Takeshi Kiyoi , Mie Kurata , Noriyoshi Miura , Tadahiko Kikugawa , Shigeki Higashiyama , Takashi Saika
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 141)
DOI
10.1200/JCO.2022.40.6_suppl.141
Abstract #
141
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Anna S. Trigos
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate-specific membrane antigen expression in endothelial cells of renal tumor-associated neovasculature and risk of recurrence for renal cell carcinoma.
First Author: Tadahiko Kikugawa
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA-based PET as an imaging biomarker of androgen receptor signaling in high-risk localized and locally advanced prostate cancer (PCa).
First Author: Keara English
Poster
2024 ASCO Genitourinary Cancers Symposium
ProstACT GLOBAL: A phase 3 study of best standard of care with and without 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer progressing despite prior treatment with a novel androgen axis drug.
First Author: Charlotte Hawkins